11.87
0.19 (1.58%)
| Penutupan Terdahulu | 11.68 |
| Buka | 11.76 |
| Jumlah Dagangan | 2,087 |
| Purata Dagangan (3B) | 13,187 |
| Modal Pasaran | 839,782,464 |
| Harga / Pendapatan (P/E TTM) | 84.75 |
| Harga / Pendapatan (P/E Ke hadapan) | 270.27 |
| Harga / Jualan (P/S) | 2.42 |
| Harga / Buku (P/B) | 3.10 |
| Julat 52 Minggu |
| Margin Keuntungan | -4.40% |
| Margin Operasi (TTM) | 0.96% |
| EPS Cair (TTM) | -0.210 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 42.30% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 55.34% |
| Nisbah Semasa (MRQ) | 2.76 |
| Aliran Tunai Operasi (OCF TTM) | 6.08 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 6.82 M |
| Pulangan Atas Aset (ROA TTM) | 1.99% |
| Pulangan Atas Ekuiti (ROE TTM) | -6.78% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Pharming Group N.V. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 3.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -4.0 |
| Purata | -1.00 |
|
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Institusi | 0.08% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Mac Alpha Capital Management, Lp | 30 Jun 2026 | 2,148,144 |
| Silverberg Bernstein Capital Management Llc | 30 Jun 2026 | 41,547 |
| Knoll Capital Management, Llc | 30 Jun 2026 | 4,091 |
| Nalls Sherbakoff Group, Llc | 30 Jun 2026 | 870 |
| Optiver Holding B.V. | 30 Jun 2026 | 305 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |